TMCnet News
Global Cardiac Biomarkers Market Worth 2,225.9 Million by 2022 - Side Effects like Skeletal Muscle Injury Hindering Growth - Research and MarketsResearch and Markets has announced the addition of the "Global Cardiac Biomarkers Market Insights, Opportunity, Analysis, Market Shares And Forecast 2016 - 2022" report to their offering. The global cardiac biomarker market is expected to generate the revenue of $2,225.9 million by 2022, registering a CAGR of 19.5% from 2016 to 2022. The prevention of cardiac diseases, by active monitoring the heart conditions by using cardiac biomarker testing is the newest approach for obtaining fastest output of immediate diagnosing and treatment of cardiac diseases. Cardiac biomarkers are made by protein-based traceable substances used as an indicator to assess biological state and for diagnosing the proactive purposes associated with heart. Cardiac biomarkers are also used as risk calculation for various cardiovascular diseases (CVDs), including myocardial congestive heart failure, infraction, acute coronary syndrome (ACS (News - Alert)) amng other diseases. The promising features of markers such as high accuracy, rapid outcomes and affordable pricing of cardiac point of care (POC) testing is supporting the market of cardiac biomarker for the growth, worldwide. To keep the momentum stable of cardiac marker tests, the key manufacturers offers customized solutions. However, limited availability in some cases and side effects such as skeletal muscle injury is hindering the growth of cardiac biomarkers market. However, concerns related to single measurement cardiac biomarkers, high pricing of the devices and certain government regulations is expected to restrain the market to grow. Companies Mentioned:
Key Topics Covered: 1. Introduction 2. Market Overview 3. Market Determinants 4. Market Segmentation 5. Geographical Analysis 6. Company Profile For more information visit http://www.researchandmarkets.com/research/6fhq5d/global_cardiac View source version on businesswire.com: http://www.businesswire.com/news/home/20160628006282/en/ |